Owned and operated by scientists with decades of experience in biomarker-based drug development, clinical trial strategies and patient stratification approaches, Noble Life Sciences provides services including cellular and animal based disease models and a proven biomarker validation platform for early stage drug and diagnostic product development.
Noble Life Sciences provides integrated preclinical services designed to accelerate drug development. Services include drug pharmacology, disease models, early safety assessments, biomarker validation and tumor profiling, cell line development, and analytical testing. We are committed to providing a strong scientific foundation to enable your preclinical decisions.
One of the biggest challenges in preclinical research is procuring high quality animal services to support your drug development mission. With numerous certifications and accreditations and backed by years of experience in animal housing and husbandry, Noble offers our clients the highest quality vivarium services with a responsive and highly flexible approach to your needs.
Noble is led by a team of scientists with deep expertise in early-stage drug development, biomarker discovery and validation, and specialized models for driving drug development. In addition to offering standard services, Noble's professional staff can implement personalized medicine approaches to help guide your research and development programs.